Germline BRCA2 Mutation in a Patient with Fallopian Tube Carcinoma: A Case Report
- 31 May 2000
- journal article
- case report
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 77 (2), 319-320
- https://doi.org/10.1006/gyno.2000.5740
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cancer Risks in BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum*1Obstetrics & Gynecology, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsThe New England Journal of Medicine, 1997
- Early Occurrence and Prognostic Significance of p53 Alteration in Primary Carcinoma of the Fallopian TubeGynecologic Oncology, 1997
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- The genetic attributable risk of breast and ovarian cancerCancer, 1996
- Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.Journal of Clinical Oncology, 1996
- Linkage analysis of 26 Canadian breast and breast-ovarian cancer familiesHuman Genetics, 1995
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- PRIMARY CARCINOMA OF THE FALLOPIAN TUBEObstetrical & Gynecological Survey, 1961